The sky might be the limit for a biotech company with a pipeline candidate that beat the world's top-selling drug in a ...

Analyst Jason McCarthy from Maxim Group reiterated a Buy rating on Gain Therapeutics (GANX – Research Report) and keeping the price ...

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Heron Therapeutics Inc (HRTX) stock saw a modest uptick, ending the day at $2.02 which represents a slight increase of $0.07 or 3.59% from the prior close of $1.95. The stock opened at $1.99 and ...

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $36.41 which represents a slight increase of $2.07 or 6.03% from the prior close of $34.34. The stock opened at $35.06 and ...

Analyst Ed Arce from H.C. Wainwright maintained a Buy rating on Aligos Therapeutics (ALGS – Research Report) and keeping the price target ...

Shares of Applied Therapeutics (NASDAQ: APLT) had skyrocketed 70.5% as of 10:43 a.m. ET on Wednesday. The huge gain came after the U.S. Food and Drug Administration (FDA) told the company that an ...

Data support the ability of GT-02287 to prevent several steps in the disease cascade resulting from GCase misfolding and dysfunctionBETHESDA, Md., March 05, 2024 (GLOBE NEWSWIRE) ...

BETHESDA, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the ...

Foghorn Therapeutics Inc. (FHTX) shares rallied 9.5% in the last trading session to close at $9.72. This move can be attributable to notable volume with a higher number of shares being traded than in ...

Summit Therapeutics acquired rights to ivonescimab outside of China and Australia. With Keytruda sales up around $25 billion ...

Is Summit Therapeutics stock a buy? Even with the stellar phase 3 results for ivonescimab, buying a clinical-stage biotech stock is always associated with risks. There are also tr ...